MedTrace Logo

Association of Genes to Resistance to Weight Loss in Obese Patients

NCT00858221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 824

Last updated 2009-10-20

No results posted yet for this study

Summary

The overall goal of this study is to determine whether variations in the perilipin, and several other, genes would be a useful tool for physicians who are caring for morbidly obese patients to guide therapy.

The main hypotheses to be tested is that sequence variations (polymorphisms) in the perilipin gene and several other obesity-related genes are associated with resistance to weight loss for obese individuals on energy restricted diets, potentially playing a role in the development of obesity related complications.

Conditions

Sponsors & Collaborators

  • Interleukin Genetics, Inc.

    lead INDUSTRY

Principal Investigators

  • Karen Shaver, MS · Interleukin Genetics

  • Christopher D. Still, MD · Geisinger Clinic

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-04-30
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00858221 on ClinicalTrials.gov